Cargando…
KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST
The aim of this study was to determine the minimal set of genetic alterations required for the development of a very low risk clinically symptomatic gastro-intestinal stromal tumour within the stomach wall. We studied the genome of a very low-risk gastric gastro-intestinal stromal tumour by whole-ge...
Autores principales: | Klinke, Olaf Karl, Mizani, Tuba, Baldwin, Gouri, Bancel, Brigitte, Devouassoux-Shisheboran, Mojgan, Scoazec, Jean-Yves, Bringuier, Pierre-Paul, Feederle, Regina, Jauch, Anna, Hinderhofer, Katrin, Taniere, Philippe, Delecluse, Henri-Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477893/ https://www.ncbi.nlm.nih.gov/pubmed/26102504 http://dx.doi.org/10.1371/journal.pone.0130149 |
Ejemplares similares
-
Pathobiology of ovarian carcinomas
por: Devouassoux-Shisheboran, Mojgan, et al.
Publicado: (2015) -
Epstein–Barr virus particles induce centrosome amplification and chromosomal instability
por: Shumilov, Anatoliy, et al.
Publicado: (2017) -
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region
por: Cassier, P A, et al.
Publicado: (2010) -
LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma
por: Klug, Lillian R., et al.
Publicado: (2018) -
Secondary KIT mutations: the GIST of drug resistance and sensitivity
por: Napolitano, Andrea, et al.
Publicado: (2019)